BMY — Recent News Coverage
All news mentioning BMY in ESEN's AI-graded feed
News stories with BMY as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on BMY. See /coverage/BMY for the 30-day aggregate.
SEEKINGALPHA
·
2026-08-04
HIGH
BULLISH
CORR0.72
Bristol-Myers Squibb, AstraZeneca deal talks remain active - report
$BMY
$AZN
◈ ESEN AI
Bristol-Myers Squibb (BMY) and AstraZeneca (AZN) remain engaged in active merger discussions, according to reporting. M&A negotiations of this scale represent a potential industry-consolidating transaction that could re…
RTTNEWS.COM
·
2026-08-04
HIGH
BEARISH
CORR0.58
BioNTech Q2 Net Loss Widens, Lowers FY26 Revenue Outlook; Stock Falls In Pre-Market
$BNTX
$BMY
◈ ESEN AI
BioNTech reported a significant deterioration in Q2 financial performance, with net losses more than doubling year-over-year to €820.8 million. This widening loss, coupled with a downward revision to full-year 2026 reve…
SEEKINGALPHA
·
2026-08-03
NEUTRAL
NEUTRAL
CORR0.15
Potential AstraZeneca purchase of Bristol-Myers unlikely for now - analyst
$AZN
$BMY
◈ ESEN AI
Analyst commentary on a potential acquisition of Bristol-Myers Squibb (BMY) by AstraZeneca (AZN) suggests such a transaction remains unlikely in the near term. This represents a reassessment of earlier market speculatio…
FINANCE.YAHOO.COM
·
2026-08-03
HIGH
BEARISH
CORR0.72
AstraZeneca shares slump after $400bn BMS merger rumours
$AZN
$BMY
◈ ESEN AI
AstraZeneca shares declined on merger speculation involving Bristol Myers Squibb, with reports suggesting a potential $400 billion combination. The immediate market reaction penalized AZN, indicating investor concern ab…
SEEKINGALPHA
·
2026-08-03
NEUTRAL
NEUTRAL
CORR0.35
AstraZeneca tops pharma growth rankings while Bristol Myers trails amid merger talks
$AZN
$BMY
◈ ESEN AI
AstraZeneca has outperformed peer benchmarks in pharma growth metrics, signaling stronger pipeline execution and commercial momentum relative to competitors. This reflects operational discipline and successful market po…
SEEKINGALPHA.COM
·
2026-08-03
NEUTRAL
NEUTRAL
CORR0.42
Wall Street Breakfast Podcast: Say Hello To Qwen3.8-Max (undefined:BABA)
$BABA
$AZN
$BMY
◈ ESEN AI
Alibaba announced Qwen3.8-Max, advancing its competitive position in the large language model race. This launch represents continued investment in generative AI infrastructure and signals intensifying competition agains…
FORTUNE.COM
·
2026-08-02
HIGH
BULLISH
CORR0.72
AstraZeneca said to have explored Bristol Myers merger
$AZN
$BMY
◈ ESEN AI
AstraZeneca has explored a potential merger with Bristol Myers Squibb, a $133 billion pharmaceutical player, signaling strategic intent to consolidate market position. Pharma M&A activity of this magnitude typically com…
SEEKINGALPHA
·
2026-08-02
HIGH
BULLISH
CORR0.72
AstraZeneca, Bristol Myers held merger talks, Financial Times reports
$AZN
$BMY
◈ ESEN AI
AstraZeneca and Bristol Myers Squibb engagement in merger discussions represents a potentially transformational consolidation event in the pharmaceutical sector. Large-cap M&A activity of this magnitude typically comman…
SEEKINGALPHA.COM
·
2026-07-30
NEUTRAL
BULLISH
CORR0.58
Bristol-Myers Squibb Stock: Why I'm Still Bullish After Q2 (NYSE:BMY)
$BMY
◈ ESEN AI
Bristol-Myers Squibb (BMY) has reached a 52-week high following robust second-quarter earnings results and management's upward revision of earnings-per-share guidance. The stock's strength reflects confidence in the com…
CNBC
·
2026-07-20
NEUTRAL
BULLISH
CORR0.72
Jim Cramer's top 10 things to watch in the stock market Monday
$NVDA
$BMY
◈ ESEN AI
NVDA and the broader semiconductor complex are showing strength as institutional adoption of AI-capable chips accelerates. Bristol Myers Squibb's capital deployment toward Nvidia hardware for drug discovery validates th…
FINANCE.YAHOO.COM
·
2026-07-14
HIGH
BEARISH
CORR-0.52
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
$PFE
$ABBV
$BMY
◈ ESEN AI
The Trump administration's renewed focus on drug-pricing negotiations represents a structural headwind for large-cap pharmaceutical companies, particularly Pfizer, AbbVie, and Bristol Myers Squibb. Policy-driven pricing…
FINANCE.YAHOO.COM
·
2026-07-06
NEUTRAL
NEUTRAL
CORR0.42
Is Bristol Myers Squibb's 4.3% Dividend Yield Safe? Here's What Investors Need to Know.
$BMY
◈ ESEN AI
Bristol Myers Squibb's elevated dividend yield of 4.3% reflects both investor appetite for pharma income and underlying concerns about the company's valuation and growth trajectory. The yield sits above both sector and …
SEEKINGALPHA.COM
·
2026-07-04
NEUTRAL
BULLISH
CORR0.42
Bristol Myers Squibb Stock: Pain First, Payoff Later? (NYSE:BMY)
$BMY
◈ ESEN AI
Bristol Myers Squibb (BMY) has been flagged as undervalued within the pharmaceutical sector, with analyst commentary emphasizing a disconnect between current valuation and fundamental earnings power. The thesis centers …
FINANCE.YAHOO.COM
·
2026-06-30
NEUTRAL
BEARISH
CORR0.42
Is Bristol-Myers Squibb Company (BMY) Stock at Risk From Proposed Medicare Drug Price Negotiation Updates?
$BMY
◈ ESEN AI
Bristol-Myers Squibb (BMY) faces potential headwinds from proposed updates to the Medicare Drug Price Negotiation Program, a regulatory mechanism introduced under the Inflation Reduction Act. The proposed changes repres…
FINANCE.YAHOO.COM
·
2026-06-26
NEUTRAL
NEUTRAL
CORR0.42
Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
$BMY
$JNJ
◈ ESEN AI
Bristol Myers Squibb (BMY) and Johnson & Johnson (JNJ) represent divergent strategies within large-cap healthcare. BMY's positioning in specialty medicines creates concentrated exposure to high-margin therapeutic areas,…
SEEKINGALPHA.COM
·
2026-06-18
LOW
NEUTRAL
CORR0.15
Bristol-Myers Squibb Company declares $0.63 dividend (NYSE:BMY)
$BMY
◈ ESEN AI
Bristol-Myers Squibb (BMY) has declared a quarterly dividend of $0.63 per share, maintaining consistency with its previous distribution level. This announcement represents a routine capital allocation decision with no m…
FINANCE.YAHOO.COM
·
2026-06-13
NEUTRAL
BULLISH
CORR0.42
How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.
$BMY
$PFE
◈ ESEN AI
Bristol Myers Squibb (BMY) is the focal point of this dividend safety assessment, with the company offering a 4.5% yield that significantly exceeds broad market averages. This above-market income profile attracts yield-…
FLIPBOARD.COM
·
2026-06-11
NEUTRAL
BULLISH
CORR0.42
Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.
$BMY
◈ ESEN AI
Bristol Myers Squibb (BMY) continues to demonstrate capital allocation discipline through an 18-year consecutive dividend increase streak, a notable achievement in the pharmaceutical sector where cash generation and sha…
EXPLORE OTHER FILTERS